0.7553

20.46% 0.1283

Matinas Biopharma Holdings Inc (MTNB)

Panoramica Notizia Cronologia dei prezzi Forum Previsione

Precedente Chiudi:

$0.627

Aprire:

$0.6611

Volume 24 ore:

1.68M

Relative Volume:

9.86

Capitalizzazione di mercato:

$4.84M

Reddito:

$1.10M

Utile/perdita netta:

$-11.23M

Rapporto P/E:

-0.373

EPS:

-2.025

Flusso di cassa netto:

$-6.61M

1 W Prestazione:

+19.20%

1M Prestazione:

-4.99%

6M Prestazione:

+17.34%

1 anno Prestazione:

-26.67%

Intervallo 1D:

$0.615

$0.9065

Intervallo di 1 settimana:

$0.612

$0.9065

Portata 52W:

$0.48

$3.09

Matinas Biopharma Holdings Inc Stock (MTNB) Company Profile

Nome

Matinas Biopharma Holdings Inc

Settore

Healthcare (1096)

Industria

Biotechnology (616)

Telefono

908-443-1860

Indirizzo

1545 Route 206 South, Suite 302, Bedminster, NJ

Dipendente

Cinguettio

@MatinasBio

Prossima data di guadagno

2026-08-13

Ultimi documenti SEC

MTNB's Discussions on Twitter

Compare MTNB vs VRTX, REGN, ARGX, ALNY, RVMD

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
MTNB Matinas Biopharma Holdings Inc	0.7553	4.84M	1.10M	-11.23M	-6.61M	-2.025
VRTX Vertex Pharmaceuticals Inc	485.39	123.19B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	664.52	69.67B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	877.62	54.58B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	298.76	39.89B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	186.88	39.73B	742.00K	-1.37B	-1.07B	-7.0731

Matinas Biopharma Holdings Inc Stock (MTNB) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2021-05-11	Downgrade	Piper Sandler	Overweight → Neutral
2020-08-26	Ripresa	Piper Sandler	Overweight
2020-01-27	Iniziato	Piper Sandler	Overweight
2020-01-24	Iniziato	SunTrust	Buy
2020-01-23	Iniziato	SunTrust	Buy
2020-01-09	Iniziato	Aegis Capital	Buy
2019-06-26	Iniziato	H.C. Wainwright	Buy

Mostra tutto

Matinas Biopharma Holdings Inc Borsa (MTNB) Ultime notizie

Jul 06, 2026

MSN Money - MSN

Jul 06, 2026

Jul 01, 2026

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Jul 01, 2026

Jun 29, 2026

Price to earnings forward of Matinas Biopharma Holdings, Inc. – AMEX:MTNB - TradingView

Jun 29, 2026

Price to earnings forward of Matinas BioPharma Holdings, Inc. – GETTEX:6LJ0 - TradingView

Jun 29, 2026

Jun 28, 2026

Price to book forward of Matinas Biopharma Holdings, Inc. – AMEX:MTNB - TradingView

Jun 28, 2026

Price to sales forward of Matinas BioPharma Holdings, Inc. – GETTEX:6LJ0 - TradingView

Jun 28, 2026

Enterprise value to revenue forward of Matinas BioPharma Holdings, Inc. – GETTEX:6LJ0 - TradingView

Jun 28, 2026

Enterprise value to EBIT forward of Matinas BioPharma Holdings, Inc. – GETTEX:6LJ0 - TradingView

Jun 28, 2026

Jun 27, 2026

Matinas BioPharma receives NYSE delisting plan extension - Investing.com UK

Jun 27, 2026

Matinas BioPharma receives NYSE delisting plan extension By Investing.com - Investing.com Nigeria

Jun 27, 2026

Jun 26, 2026

Matinas BioPharma Receives NYSE American Non-Compliance Notice, Granted Plan Period to Regain Listing Standards - Minichart

Jun 26, 2026

Matinas BioPharma (MTNB) Faces NYSE Equity Compliance Challenge - GuruFocus

Jun 26, 2026

Matinas BioPharma Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView

Jun 26, 2026

Matinas BioPharma (NYSE: MTNB) put on NYSE American equity compliance plan to avoid delisting - Stock Titan

Jun 26, 2026

Matinas BioPharma's High-Stakes Gamble to Keep its NYSE Listing Alive - BriefGlance

Jun 26, 2026

Matinas BioPharma Holdings, Inc. Actuals & Estimates (GETTEX:6LJ0) - TradingView

Jun 26, 2026

Jun 25, 2026

Matinas BioPharma Holdings, Inc. Actuals & Estimates (AMEX:MTNB) - TradingView

Jun 25, 2026